A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
Active, not recruiting · NCT03796962 · Registry updated 2024-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy | brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder | Active, not recruiting | Phase 2 | 2024-09-24 | NCT03796962 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novotech Health Holdings Pte. Ltd. | 1 |
| Xenon Pharmaceuticals Inc. | 9 |
95 results · Page 1 of 4
Research sites
Swipe the table sideways for more columns.